Skip to main content
Premium Trial:

Request an Annual Quote

Packard BioScience Buys Canadian Firm BioSignal

Premium

MERIDEN, Conn.--Packard BioScience here said it has acquired BioSignal, a Montreal-based biotechnology research firm. Packard paid approximately $8.5 million for the interest in the company that it did not already own. Packard said it plans to unite BioSignal's gene cloning expertise with the advanced biochip technology that Packard, Motorola, and Argonne National Laboratory recently announced they will develop jointly. Packard said it will be able to incorporate validated drug targets into high-throughput screening platforms for pharmaceutical and biotechnology research.

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.